Matthew G. Guenther
Synta Pharmaceuticals (United States)
ORCID: 0009-0006-6779-1195Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Papers
Driven by 6 papers. Top paper: “Nuclear receptor corepressors partner with class II histone deacetylases in a Sin3-independent repression pathway”.
Jinsong Zhang, Eric A. Miska, Matthew G. Guenther, Tony Kouzarides, Mitchell A. Lazar +1 more
Matthew G. Guenther, Richard W. Carthew, Mitchell A. Lazar, Jinsong Zhang
Jiujiu Yu, Gary D. Kao, Tim J. Yen, Mitchell A. Lazar, Matthew G. Guenther
Orr Barak, Mitchell A. Lazar, Matthew G. Guenther
Christopher Fiore, Yogesh K. Chutake, Elisha R. Verhaar, Patrick C. Strasser, Mei Wei Chen +18 more
Pooneh Koochaki, Sayed Matar, Fatme Ghandour, Marc Machaalani, Eddy Saad +22 more